Literature DB >> 19262712

Chemotherapy for advanced gastric cancer: a new milestone lies ahead.

Hiroya Takiuchi1.   

Abstract

Entities:  

Year:  2007        PMID： 19262712      PMCID： PMC2632534     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  12 in total

1.  Standard of care for gastric cancer based on meta-analysis? Treading on thin ice or it is very nice!

Authors:  Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2006-12-01       Impact factor: 44.544

Review 2.  Disparities in gastric cancer chemotherapy between the East and West.

Authors:  Atsushi Ohtsu; Shigeaki Yoshida; Nagahiro Saijo
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

3.  Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002).

Authors:  Hiroya Takiuchi; Hiroyuki Narahara; Toshimasa Tsujinaka; Masahiro Gotoh; Sei-ichiro Kawabe; Ken-ichi Katsu; Hiroyasu Iishi; Masaharu Tatsuta; Kazumasa Fujitani; Hiroshi Furukawa; Tetsuo Taguchi
Journal:  Jpn J Clin Oncol       Date:  2005-09-01       Impact factor: 3.019

4.  Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.

Authors:  U Vanhoefer; P Rougier; H Wilke; M P Ducreux; A J Lacave; E Van Cutsem; M Planker; J G Santos; P Piedbois; B Paillot; H Bodenstein; H J Schmoll; H Bleiberg; B Nordlinger; M L Couvreur; B Baron; J A Wils
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

5.  Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancer.

Authors:  Kazumasa Fujitani; Hiroyuki Narahara; Hiroya Takiuchi; Toshimasa Tsujinaka; Eriko Satomi; Masahiro Gotoh; Motohiro Hirao; Hiroshi Furukawa; Tetsuo Taguchi
Journal:  Oncology       Date:  2005-11-25       Impact factor: 2.935

6.  Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Authors:  Eric Van Cutsem; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Marie-Laure Risse; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

7.  Chemotherapy for advanced gastric cancer: review of global and Japanese status.

Authors:  Wasaburo Koizumi
Journal:  Gastrointest Cancer Res       Date:  2007-09

8.  Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

Authors:  Atsushi Ohtsu; Yasuhiro Shimada; Kuniaki Shirao; Narikazu Boku; Ichinosuke Hyodo; Hiroshi Saito; Noboru Yamamichi; Yoshinori Miyata; Nobumasa Ikeda; Seiichiro Yamamoto; Haruhiko Fukuda; Shigeaki Yoshida
Journal:  J Clin Oncol       Date:  2003-01-01       Impact factor: 44.544

9.  Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.

Authors:  K Yamaguchi; T Shimamura; I Hyodo; W Koizumi; T Doi; H Narahara; Y Komatsu; T Kato; S Saitoh; T Akiya; M Munakata; Y Miyata; Y Maeda; H Takiuchi; S Nakano; T Esaki; F Kinjo; Y Sakata
Journal:  Br J Cancer       Date:  2006-06-19       Impact factor: 7.640

10.  Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer.

Authors:  W Koizumi; S Tanabe; K Saigenji; A Ohtsu; N Boku; F Nagashima; K Shirao; Y Matsumura; M Gotoh
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.